Mordwinkin Nicholas Michael 4
4 · Kezar Life Sciences, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Mordwinkin Nicholas Michael
Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-07+275,000→ 275,000 totalExercise: $0.93Exp: 2034-01-06→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]One forty-eighth (1/48th) of the shares shall vest on a monthly basis commencing on January 7, 2024, subject to the Reporting Person continuing to provide service through each such date.